Opportunities for improvement in managing pre-PPQ biologic product knowledge
Related Experiment Video
Updated: Jan 14, 2026

Operating and Biocontainment Procedures of a Facility for Laboratory Mice with a Natural Microbiome: Immunophenotyping Procedure
Published on: December 13, 2024
Beth Fulton1, Theo Zacharatos2, Igor Gorsky3
1QRM Consultant, ValSource Inc., USA bfulton@valsource.com.
Abstract:
Knowledge management (KM) is vital for supporting product quality throughout a biologic drug product's lifecycle. This paper presents suggestions for management of pre-PPQ (Process Performance Qualification) knowledge management for biologic manufacturing organizations. This topic was presented at the 2024 PDA Annual conference, with subjective audience survey questions that were employed in real time to customize the talking points for the presentation of KM suggestions.This paper presents a lifecycle knowledge management concept called the CQA (Critical Quality Attribute) Knowledge Accessibility Maintenance Loop (CQA-KAML). This lifecycle has been created to help organizations effectively find and manage CQA-relevant knowledge starting in the pre-PPQ phase of biologic product development to align with ICH (International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use) Q10 and other regulatory guidances.
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Biopharmaceutics and Pharmacokinetics: Overview
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Preclinical Development: Overview
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Methods of Documentation II: POMR

